SEPTEOS has a total of 30 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Brazil and United States. Its main competitors in its focus markets pharmaceuticals, environmental technology and basic materials chemistry are MO ZHAOQIN, ASHMONT HOLDINGS LTD and DALMIA CT FOR BIOTECHNOLOGY.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Brazil | 5 | |
#3 | United States | 5 | |
#4 | France | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | China | 3 | |
#7 | Australia | 1 | |
#8 | Canada | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Basic materials chemistry | |
#4 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Tesse Nicolas | 24 |
#2 | Nicolas Tesse | 6 |
Publication | Filing date | Title |
---|---|---|
FR3048612A1 | POTENTIALIZED TULATHROMYCIN | |
US2017216440A1 | Potentiated antimicrobial agents | |
FR3025719A1 | POTENTIAL ANTIMICROBIALS | |
BR112013014189A2 | pharmaceutical composition, use of a potentiating agent and use of a composition | |
EP2648704A1 | Anti-microbial composition | |
BRPI1010948A2 | antibacterial composition, pharmaceutical composition or medication, uses of the composition and in vitro process for preparing a surface |